Newron Pharmaceuticals S.p.A. - ROE

The ROE as of July 2026 (TTM) for Newron Pharmaceuticals S.p.A. (NP5.DE) is 277.88%

According to Newron Pharmaceuticals S.p.A.’s latest financial reports and current stock price. The company's current ROE is 277.88%. This represents a change of -41.10% compared to the average of 471.76% of the last 4 quarters.

Newron Pharmaceuticals S.p.A. (NP5.DE) Historical ROE (quarterly & annually)

How has NP5.DE ROE performed in the past?

The mean historical ROE of Newron Pharmaceuticals S.p.A. over the last ten years is 66.24%. The current 277.88% ROE has changed 319.48% with respect to the historical average. Over the past ten years (40 quarters), NP5.DE's ROE was at its highest in in the December 2024 quarter at 1.74%. The ROE was at its lowest in in the December 2021 quarter at -187.90%.

Newron Pharmaceuticals S.p.A. (NP5.DE) ROE by Quarter and Year

Discovering the peaks and valleys of Newron Pharmaceuticals S.p.A. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Newron Pharmaceuticals S.p.A. (NP5.DE) Average ROE

How has NP5.DE ROE performed in the past?

The current ROE of Newron Pharmaceuticals S.p.A. (NP5.DE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Newron Pharmaceuticals S.p.A. (NP5.DE) ROE vs. Peers

How is NP5.DE’s ROE compared to its peers?

Newron Pharmaceuticals S.p.A.’s ROE is greater than Medios AG (2.69%), less than M1 Kliniken AG (18.60%), greater than Stratec SE (-1.37%), greater than High Tide Inc. (-43.38%), greater than Formycon AG (-16.02%), less than Mediclin AG (11.90%), greater than Zura Bio Limited (-54.60%), less than DocCheck AG (13.28%), greater than Geratherm Medical AG (-4.05%), less than Heidelberg Pharma AG (444.89%),

Build a custom stock screener for Newron Pharmaceuticals S.p.A. (NP5.DE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Newron Pharmaceuticals S.p.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Newron Pharmaceuticals S.p.A. (NP5.DE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Newron Pharmaceuticals S.p.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.